All lobbying filings
FEDERAL HEALTH COUNSEL, LLC
FEDERAL HEALTH COUNSEL, LLC filed a Q3 report for AMGEN, INC. on November 12, 2025.
Lobbying for AMGEN, INC. · Pharmaceutical Company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Nov 12, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia
Lobbying activity
1
Issues related to the implementation of the Medicare Drug Negotiations and the calculation of the Medicaid Rebate and Best Price. issues relating to MFN pricing and other price controls in drugs.